SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-18-002397
Filing Date
2018-12-19
Accepted
2018-12-19 16:01:12
Documents
4
Period of Report
2018-12-14
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 11576
2 EX-99.1 lxrp_ex991.htm EX-99.1 6815
3 lxrp_ex991img1.jpg GRAPHIC 3240
4 lxrp_ex991img2.jpg GRAPHIC 3028
  Complete submission text file 0001640334-18-002397.txt   28577
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 181243499
SIC: 1000 Metal Mining